`
`Search Results/ Beta ClinicalTrials.gov
`
`ClinicalTrials.goem>
`
`EXHIBIT No.'Z.O'Lf1
`\ .. \7l~M C
`The U.S. government does not review or approve the safety and science of all studies listed on this
`website.
`Rea,1 our fL,11 d1sclCJ 1mer (httR s.1/b~t3 c lm1c:iltr1als gov/full-lJ1scla1r:1er) for det ail s
`
`National Library of Medicine
`National Center for Biotechnology Information
`
`ClinicalTrials.gov is a website and online database of clinical research studies and information about their res ults. The National Library of
`Medicine (NLM) maintains the webs ite. The study sponsor or investigator submits information about their study to ClinicalTrials.gov and is
`responsible for the safety, science, and accuracy of any study they li st.
`
`Before joining a study, talk to your hea lth care professional about possibl e risks and benefits To learn more about taking part in studies, read
`Learn About Studies (httRsl/beta.ciinicaltr1als.gov/about-stud1es).
`
`Search Results
`
`Viewing 1-8 out of 8 studies
`
`•COMPLETED
`
`Gene Therapy in Treating Patients With Cancer
`
`CONDITIONS
`
`Cancer
`
`LOCATIONS
`
`Q Boston, Massachusetts, United States
`
`e COMPL ETED
`
`Monoclonal Antibody Plus lnterleukin-2 in Treating Patients With Leukemia or Lymphoma
`
`CONDITIONS
`
`Leukemia Lymphoma
`
`LOCATIONS
`
`9 Boston, Massachusetts, United States
`
`e SUSPENDED
`
`Phase II/ Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
`
`CONDITIONS
`
`Metastatic Cancers
`
`LOCATIONS
`
`9 Providence, Rhode Island, United States
`
`• SLJSDE NDED
`
`Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
`
`CONDITIONS
`
`Monitor Adverse Events
`
`LOCATION S
`
`https://beta.clinicaltrials.gov/search?distance=SO&term=Richard Junghans
`
`1/2
`
`UPenn Ex. 2049
`Miltenyi v. UPenn
`IPR2022-00855
`
`
`
`1/12/23, 12:56 PM
`
`~ Providence, Rhode Island, United States
`
`• sus::iENCEJ
`
`Search Results I Beta ClinicalTrials.gov
`
`Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
`
`CONDITIONS
`
`Breast Cancer
`
`LOCATIONS
`
`9 Boston, Massachusetts, United States
`
`9 Providence, Rhode Island, United States
`
`e TERMINATED
`
`Trial of Second Generation Designer T Cells in Colorectal Carcinoma
`
`CONDITIONS
`
`Colorectal Cancer
`
`LOCATIONS
`
`~ Providence, Rhode Island, United States
`
`• SuS?ENu[8
`
`Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
`
`CONDITIONS
`
`Prostate Cancer
`
`LOCATIONS
`
`Q Providence, Rhode Island, United States
`
`Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer
`
`CONDITIONS
`
`Gastric Cancer
`
`LOCATIONS
`
`Location not provided
`
`https://beta.clinicaltrials.gov/search?distance=50&term=Richard Junghans
`
`2/2
`
`UPenn Ex. 2049
`Miltenyi v. UPenn
`IPR2022-00855
`
`